BCC
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CellFX Treat & Resect Low-Risk BCC Feasibility Study (NCT04918381) | Pulse Biosciences, Inc. | 2021-06-02 |
| Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study (NCT02007317) | Oshadi Drug Administration | 2013-11-01 |
Track BCC automatically
Every clearance here is in the API, with alerts when new ones post.